Anti-GP39

Anti-GP39 Uses, Dosage, Side Effects, Food Interaction and all others data.

Anti-GP39 is under investigation in clinical trial NCT03605927 (CD40-L Blockade for Prevention of Acute Graft-versus-host Disease).

Trade Name Anti-GP39
Generic Toralizumab
Toralizumab Other Names Anti-CD 154 human-mouse monoclonal antibody, Anti-CD40L, Anti-GP39, Toralizumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Anti-GP39
Anti-GP39

Innovators Monograph

You find simplified version here Anti-GP39

*** Taking medicines without doctor's advice can cause long-term problems.
Share